0.0001
0.0000
(0.00%)
At close: January 30 at 3:00:00 PM EST
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-17,991.0000
-31,845.0000
-35,001.0000
-28,166.0000
Investing Cash Flow
258.0000
-66.0000
2,056.0000
33,792.0000
Financing Cash Flow
-2,090.0000
8,812.0000
50,788.0000
-3,438.0000
End Cash Position
4,994.0000
19,468.0000
42,567.0000
24,724.0000
Income Tax Paid Supplemental Data
--
--
--
5.0000
Interest Paid Supplemental Data
1,216.0000
1,365.0000
728.0000
828.0000
Capital Expenditure
-86.0000
-66.0000
-89.0000
--
Issuance of Capital Stock
4,887.0000
--
47,718.0000
--
Issuance of Debt
-36.0000
--
11,874.0000
797.0000
Repayment of Debt
-7,720.0000
--
-11,383.0000
-4,583.0000
Free Cash Flow
-17,991.0000
-31,911.0000
-35,090.0000
-28,166.0000
12/31/2020 - 12/11/1998
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RASP Actavia Life Sciences, Inc.
0.0040
0.00%
CMRA Comera Life Sciences Holdings, Inc.
0.0002
0.00%
SCPS Scopus BioPharma Inc.
0.0003
0.00%
KRBP Kiromic BioPharma, Inc.
0.8200
0.00%
ARTH Arch Therapeutics, Inc.
0.1810
0.00%
AVTE Aerovate Therapeutics, Inc.
2.6200
0.00%
TRVN Trevena, Inc.
1.6700
+5.70%
IMRN Immuron Limited
2.0420
-4.58%
GDTC CytoMed Therapeutics Limited
2.6400
+5.18%
RGBP Regen BioPharma, Inc.
0.0621
0.00%